KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: GDC 0084 progress update, page-4

  1. Merchant2000
    22,716 Posts.
    lightbulb Created with Sketch. 925
    clock Created with Sketch.
    22/08/17
    09:53
    Post #: 26652846
    Hopefully soon they will announce the financial details of the MSA

    Novogen has signed a Master Services Agreement (MSA) with Chiltern Oncology in relation to conduct of the phase II clinical trial of GDC-0084.

    Chiltern Oncology is a leading international contract research organization, with a specialist capability in trials of novel anti-cancer agents.

    The MSA details key terms of the proposed working relationship, but implementation of the study will be subject to further contractual negotiations.
    Last edited by Merchant2000: 22/08/17
    NRT Price at posting: 4.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The Star Entertainment Group Announces $60 Million Divestment of Sydney Event Centre Assets
right-arrow Created with Sketch.
NEWS Green Energy Major Project Status Granted to Australian Vanadium by WA Government
right-arrow Created with Sketch.
NEWS Drilling Fully Approved for Rae Copper Project with Identified Targets to Be Explored
right-arrow Created with Sketch.
NEWS Advanced Clinical Chosen as CRO for Phase 3 Osteoarthritis Trial by Paradigm
right-arrow Created with Sketch.
NEWS Dose Escalation Approved in PYC's ADOA Trial Following Safety Review
right-arrow Created with Sketch.
NEWS Key Milestones in US-Based Technology Plant Development Achieved by MTM
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.